absorbance -- Lysergol 3.93 x [10.sup.-9] Lysergic acid 3.72 x [10.sup.-8] Ergonovine 1.72 x [10.sup.-9] Ergonovine maleate 1.25 x [10.sup.-10] Ergovaline 2.40 x [10.sup.-9] Ergotamine tartrate 7.61 x [10.sup.-10] Ergocryptine 1.74 x [10.sup.-11] Bromo-ergocryptine 1.54 x [10.sup.-8] ([dagger])
Cross reaction not detected.
Therefore, we concluded that AMA-M2 and TPOAb may also be caused by
cross reactions, indicating to our patient's immune disorder which may have generated cross-reactive antibodies.
Individuals with allergy to sulfa drugs are not only at risk for type I allergic reaction (allergic shock) and other hypersensitivity reactions to antibacterial sulfonamide agents but also they may be in a higher risk of
cross reactions to nonantibacterial sulfonamides.